RESUMEN
Lymphotoxin (LT)-α regulates many biologic activities, yet little is known of the regulation of its gene. In this study, the contribution to LTA transcriptional regulation of the region between the transcription and translation start sites (downstream segment) was investigated. The LTA downstream segment was found to be required for, and alone to be sufficient for, maximal transcriptional activity in both T and B lymphocytes. The latter observation suggested that an alternate core promoter might be present in the downstream segment. Characterization of LTA mRNAs isolated from primary and from transformed human T cells under different stimulation conditions identified eight unique transcript variants (TVs), including one (LTA TV8) that initiated within a polypyrimidine tract near the 3' end of the downstream segment. Further investigation determined that the LTA downstream segment alternate core promoter that produces the LTA TV8 transcript most likely consists of a stimulating protein 1 binding site and an initiator element and that factors involved in transcription initiation (stimulating protein 1, TFII-I, and RNA polymerase II) bind to this LTA region in vivo. Interestingly, the LTA downstream segment alternate core promoter was active only after specific cellular stimulation and was the major promoter used when human T cells were stimulated with TGF-ß1 and fibroblast growth factor-7. Most importantly, this study provides evidence of a direct link for crosstalk between T cells and epithelial/stromal cells that has implications for LT signaling by T cells in the cooperative regulation of various processes typically associated with TGF-ßR and fibroblast growth factor-R2 signaling.
Asunto(s)
Factor 7 de Crecimiento de Fibroblastos/genética , Linfotoxina-alfa/biosíntesis , Linfocitos T/metabolismo , Factor de Crecimiento Transformador beta1/metabolismo , Linfocitos B/inmunología , Linfocitos B/metabolismo , Secuencia de Bases , Sitios de Unión/genética , Sitios de Unión/inmunología , Línea Celular Tumoral , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/inmunología , Proteínas de Unión al ADN/metabolismo , Células Epiteliales/inmunología , Células Epiteliales/metabolismo , Factor 7 de Crecimiento de Fibroblastos/inmunología , Factor 7 de Crecimiento de Fibroblastos/metabolismo , Regulación de la Expresión Génica/inmunología , Humanos , Células Jurkat , Linfotoxina-alfa/genética , Linfotoxina-alfa/inmunología , Datos de Secuencia Molecular , Proteína de Unión al Tracto de Polipirimidina/genética , Proteína de Unión al Tracto de Polipirimidina/inmunología , Proteína de Unión al Tracto de Polipirimidina/metabolismo , Regiones Promotoras Genéticas , ARN Polimerasa II/genética , ARN Polimerasa II/inmunología , ARN Polimerasa II/metabolismo , ARN Mensajero/genética , ARN Mensajero/inmunología , Transducción de Señal/inmunología , Factor de Transcripción Sp1/genética , Factor de Transcripción Sp1/inmunología , Factor de Transcripción Sp1/metabolismo , Células del Estroma/inmunología , Células del Estroma/metabolismo , Linfocitos T/inmunología , Factores de Transcripción TFII/genética , Factores de Transcripción TFII/inmunología , Factores de Transcripción TFII/metabolismo , Transcripción Genética/inmunología , Activación Transcripcional/inmunología , Factor de Crecimiento Transformador beta1/genética , Factor de Crecimiento Transformador beta1/inmunologíaRESUMEN
The HIV-1 virion-associated accessory protein Vpr affects both viral replication and cellular transcription, proliferation, and differentiation. We report that Vpr enhances the activity of glucocorticoids in lymphoid and muscle-derived cell lines by interacting directly with the glucocorticoid receptor and general transcription factors, acting as a coactivator. Vpr contains the signature motif LXXLL also present in cellular nuclear receptor coactivators, such as steroid receptor coactivator 1 and p300/CREB-binding protein, which mediates their interaction with the glucocorticoid and other nuclear hormone receptors. A mutant Vpr molecule with disruption of this coactivator signature motif lost its ability to influence transcription of glucocorticoid-responsive genes and became a dominant-negative inhibitor of Vpr, possibly by retaining its general transcription factor-binding activities. The glucocorticoid coactivator activity of Vpr may contribute to increased tissue glucocorticoid sensitivity in the absence of hypercortisolism and to the pathogenesis of AIDS.
Asunto(s)
Productos del Gen vpr/metabolismo , VIH-1/metabolismo , Receptores de Glucocorticoides/metabolismo , Activación Transcripcional/genética , Línea Celular , Dexametasona/farmacología , Genes Reporteros/genética , Glucocorticoides/metabolismo , Humanos , Factor de Transcripción TFIID , Factores de Transcripción TFII/genética , Factores de Transcripción TFII/inmunología , Transfección/genética , Proteínas Virales/metabolismo , Productos del Gen vpr del Virus de la Inmunodeficiencia HumanaRESUMEN
The signals that regulate T-cell activation have been studied for some time. We know that upon interaction with antigen/MHC complex, the TCR triggers the activation of a number of kinases, including tyrosine and serine/threonine kinases. The Tec family kinase IL-2- inducible T-cell kinase (ITK) plays a role in this response, but the signaling pathways that ITK regulates are less well known. Even less known are the binding partners and substrates of ITK. A paper in this issue of the European Journal of Immunology extends our knowledge on the subject by showing that ITK interacts with the transcriptional regulator TFII-I. The implications of this finding are discussed.
Asunto(s)
Proteínas Tirosina Quinasas/metabolismo , Receptores de Antígenos de Linfocitos T/metabolismo , Transducción de Señal/inmunología , Linfocitos T/inmunología , Factores de Transcripción TFII/metabolismo , Animales , Humanos , Interleucina-2/inmunología , Interleucina-2/metabolismo , FN-kappa B/inmunología , FN-kappa B/metabolismo , Proteínas Tirosina Quinasas/inmunología , Receptores de Antígenos de Linfocitos T/inmunología , Linfocitos T/metabolismo , Factores de Transcripción TFII/inmunologíaRESUMEN
Over 80% of Plasmodium falciparum genes are developmentally regulated during the parasite's life cycle with most genes expressed in a "just in time" fashion. However, the molecular mechanisms of gene regulation are still poorly understood. Analysis of P. falciparum genome shows that the parasite appears to encode relatively few transcription factors homologous to those in other eukaryotes. We used Chromatin immunoprecipitation (ChIP) to study interaction of PfTBP and PfTFIIE with stage specific Plasmodium promoters. Our results indicate that PfTBP and PfTFIIE are bound to their cognate sequence in active and inactive erythrocytic-expressed promoters. In addition, TF occupancy appears to extend beyond the promoter regions, since PfTBP interaction with the coding and 3' end regions was also detected. No PfTBP or PfTFIIE interaction was detected on csp and pfs25 genes which are not active during the erythrocytic asexual stage. Furthermore, PfTBP and PfTFIIE binding did not appear to correlate with histone 3 and/or 4 acetylation, suggesting that histone acetylation may not be a prerequisite for PfTBP or PfTFIIE promoter interaction. Based on our observations we concluded that the PfTBP/PfTFIIE-containing preinitiation complex (PIC) would be preassembled on promoters of all erythrocytic-expressed genes in a fashion independent of histone acetylation, providing support for the "poised" model. Contrary to the classical model of eukaryotic gene regulation, PIC interaction with Plasmodium promoters occurred independent of transcriptional activity and to the notion that chromatin acetylation leads to PIC assembly.
Asunto(s)
Eritrocitos/parasitología , Plasmodium falciparum/genética , Regiones Promotoras Genéticas/fisiología , Proteína de Unión a TATA-Box/genética , Factores de Transcripción TFII/genética , Acetilación , Animales , Anticuerpos Antiprotozoarios/biosíntesis , Anticuerpos Antiprotozoarios/inmunología , Western Blotting , Inmunoprecipitación de Cromatina , Regulación del Desarrollo de la Expresión Génica , Histonas/metabolismo , Humanos , Proteína 1 de Superficie de Merozoito/genética , Plasmodium falciparum/crecimiento & desarrollo , Plasmodium falciparum/inmunología , Proteínas Protozoarias/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Proteína de Unión a TATA-Box/inmunología , Proteína de Unión a TATA-Box/fisiología , Factores de Transcripción TFII/inmunología , Factores de Transcripción TFII/fisiologíaRESUMEN
Expression of the gamma-globin gene is silenced in adult humans. However, certain point mutations in the gamma-globin gene promoter are capable of maintaining expression of this gene during adult erythropoiesis, a condition called non-deletion hereditary persistence of fetal hemoglobin (HPFH). Among these, the British form of HPFH carrying a T-->C point mutation at position -198 of the Agamma-globin gene promoter results in 4-10% fetal hemoglobin in heterozygotes. In this study, we used nuclear extracts from murine erythroleukemia cells to purify a protein complex that binds the HPFH -198 gamma-globin gene promoter. Members of this protein complex were identified by mass spectrometry and include DNMT1, the transcriptional coactivator p52, the protein SNEV, and RAP74 (the largest subunit of the general transcription factor IIF). Sp1, which was previously considered responsible for HPFH -198 gamma-globin gene activation, was not identified. The potential role of these proteins in the reactivation and/or maintenance of gamma-globin gene expression in the adult transcriptional environment is discussed.
Asunto(s)
Hemoglobina Fetal/genética , Regulación del Desarrollo de la Expresión Génica , Globinas/genética , Regiones Promotoras Genéticas/fisiología , Factores de Transcripción/metabolismo , Adulto , Animales , Especificidad de Anticuerpos , Western Blotting , Fraccionamiento Celular , Línea Celular Tumoral , Cromatografía de Afinidad , ADN (Citosina-5-)-Metiltransferasa 1 , ADN (Citosina-5-)-Metiltransferasas/inmunología , ADN (Citosina-5-)-Metiltransferasas/aislamiento & purificación , ADN (Citosina-5-)-Metiltransferasas/metabolismo , Humanos , Leucemia Eritroblástica Aguda , Espectrometría de Masas , Ratones , Ratones Transgénicos , Proteínas Asociadas a Matriz Nuclear/inmunología , Proteínas Asociadas a Matriz Nuclear/aislamiento & purificación , Proteínas Asociadas a Matriz Nuclear/metabolismo , Mutación Puntual , Factor de Transcripción Sp1/inmunología , Factor de Transcripción Sp1/aislamiento & purificación , Factor de Transcripción Sp1/metabolismo , Factores de Transcripción/inmunología , Factores de Transcripción/aislamiento & purificación , Factores de Transcripción TFII/inmunología , Factores de Transcripción TFII/aislamiento & purificación , Factores de Transcripción TFII/metabolismo , Activación TranscripcionalRESUMEN
The multifunctional transcription factor TFII-I physically and functionally interacts with Bruton's tyrosine kinase in murine B cells. However, the downstream functions of TFII-I in B cells are unknown. Toward achieving this goal, we established stable posttranscriptional silencing of TFII-I in WEHI-231 immature murine B cells, which undergoes growth arrest and apoptosis either upon anti-IgM or TGF-beta signaling. In this study, we show that TFII-I promotes growth arrest of cells in a signal-dependent manner. Unlike control cells, B cells exhibiting loss of TFII-I function fail to undergo arrest upon signaling due to up-regulation of c-Myc expression and concomitant down-regulation of both p21 and p27. Loss of TFII-I is also associated with simultaneous increase in nuclear c-rel and decrease in p50 homodimer binding. Thus, besides controlling c-myc transcription, TFII-I controls B cell proliferation by regulating both nuclear translocation of c-rel and DNA-binding activity of p50 NF-kappaB.
Asunto(s)
Linfocitos B/inmunología , Proliferación Celular , Subunidad p50 de NF-kappa B/inmunología , Proteínas Proto-Oncogénicas c-rel/inmunología , Transducción de Señal/inmunología , Factores de Transcripción TFII/inmunología , Transporte Activo de Núcleo Celular/genética , Transporte Activo de Núcleo Celular/inmunología , Animales , Apoptosis/genética , Apoptosis/inmunología , Linfocitos B/citología , Linfocitos B/metabolismo , Línea Celular , Núcleo Celular/genética , Núcleo Celular/inmunología , Núcleo Celular/metabolismo , Regulación hacia Abajo/genética , Regulación hacia Abajo/inmunología , Inmunoglobulina M/inmunología , Ratones , Subunidad p50 de NF-kappa B/genética , Subunidad p50 de NF-kappa B/metabolismo , Proteínas Proto-Oncogénicas c-rel/genética , Proteínas Proto-Oncogénicas c-rel/metabolismo , Transducción de Señal/genética , Factores de Transcripción TFII/genética , Factores de Transcripción TFII/metabolismo , Factor de Crecimiento Transformador beta/inmunología , Regulación hacia Arriba/genética , Regulación hacia Arriba/inmunologíaRESUMEN
In yeast cells, independent depletion of TAFs (130, 67, 40, and 19) found specifically in TFIID results in selective effects on transcription, including a common effect on his3 core promoter function. In contrast, depletion of TAF17, which is also present in the SAGA histone acetylase complex, causes a decrease in transcription of most genes. However, TAF17-depleted cells maintain Ace1-dependent activation, and they induce de novo activation by heat shock factor in a manner predominantly associated with the activator, not the core promoter. Thus, TAF17 is broadly, but not universally, required for transcription in yeast, TAF17 depletion and TAF130 depletion each disrupt TFIID integrity yet cause different transcriptional consequences, suggesting that the widespread influence of TAF17 might not be due solely to its function in TFIID.